In breast cancer patients with obesity, the immune system is dysregulated with an increase in pro-inflammatory adipokines, such as CD8+, Th1 CD4+, and Th17 CD4+, and a decrease in anti-inflammatory adipokines, such as Th2 CD4+ and Tregs [128]. Here, CD4 is linked to breast carcinoma.